Clinical trial / 1998
Supplementing infant formula with DHA or DHA plus AA improved sweep VEP visual acuity and red blood cell lipid composition in term infants.
A double-masked trial evaluated term infant formula supplemented with DHA (0.35%) or DHA (0.36%) and AA (0.72%) compared to unsupplemented formula and a breast-fed reference group. Supplementation during the first 4 months produced differences in total red blood cell (RBC) lipid composition and led to better sweep VEP acuity at 6, 17, and 52 weeks of age, but not at 26 weeks. Supplemented infants showed RBC lipid composition and sweep VEP acuity similar to breast-fed infants, whereas unsupplemented infants differed significantly from breast-fed infants. Differences in acuity were not detected by forced choice preferential looking, and infants in all diet groups demonstrated similar growth rates and tolerance.
- Study type
- Double-masked randomized clinical trial
- Who was studied
- 108 healthy term infants (79 randomized to formula, 29 exclusively breast-fed)
- What was measured
- Blood fatty acid composition, growth, sweep VEP acuity, and forced choice preferential looking acuity
THE PAPER
Visual acuity and the essentiality of docosahexaenoic acid and arachidonic acid in the diet of term infants.
Birch EE, Hoffman DR, Uauy R, Birch DG, Prestidge C. Pediatr Res, 1998.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.